BI
LUCD icon

Binnacle Investments’s Lucid Diagnostics LUCD Stock Holding History

Binnacle Investments’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$25 Buy
+25
New +$27 ﹤0.01% 939
2025
Q2 		– Sell
-25
Closed -$37 – 825
2025
Q1 		$37 Buy
+25
New +$30 ﹤0.01% 783

Other funds holding LUCD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Binnacle Investments's LUCD Position: Q3 2025 in Review

Binnacle Investments opened a new position in Lucid Diagnostics (LUCD) in Q3 2025: 25 shares worth $25. The stake represents ﹤0.01% of the portfolio and ranks #939 among its holdings. This is a return to the name: Binnacle Investments previously reported a position in LUCD as recently as Q1 2025.

Binnacle Investments first reported a position in LUCD in Q1 2025 and has held it in 2 quarters since. The position peaked at $37 in Q1 2025. 86 funds tracked by Wall St. Rank hold LUCD as of Q3 2025.

  • Binnacle Investments held 25 shares of Lucid Diagnostics worth $25 as of Q3 2025.
  • Lucid Diagnostics was a new Binnacle Investments position in Q3 2025.
  • Lucid Diagnostics made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #939 holding.
  • Binnacle Investments first reported a position in Lucid Diagnostics in Q1 2025 and has held it in 2 quarters since.
  • Binnacle Investments's Lucid Diagnostics position peaked at $37 in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.